The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects DOI Open Access

Linan Ren,

Haiying Cui, Yao Wang

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 161, P. 114465 - 114465

Published: March 3, 2023

Lipotoxicity is the dysregulation of lipid environment and/or intracellular composition that leads to accumulation harmful lipids and ultimately organelle dysfunction, abnormal activation signaling pathways, chronic inflammation cell death. It plays an important role in development acute kidney injury disease, including diabetic nephropathy, obesity-related glomerulopathy, age-related polycystic like. However, mechanisms overload remain poorly understood. Herein, we discuss two pivotal aspects lipotoxic injury. First, analyzed mechanism kidney. Accumulating data indicate different diseases are inconsistent. Second, summarize multiple by which species affect behavior, oxidative stress, endoplasmic reticulum mitochondrial dysregulated autophagy, inflammation, highlighting central stress. Blocking molecular pathways damage may be potential therapeutic targets for antioxidant drugs play a treatment disease future.

Language: Английский

Immune cell-mediated features of non-alcoholic steatohepatitis DOI Creative Commons
Thierry Huby, Emmanuel L. Gautier

Nature reviews. Immunology, Journal Year: 2021, Volume and Issue: 22(7), P. 429 - 443

Published: Nov. 5, 2021

Non-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifestations, starting with steatosis and potentially evolving towards non-alcoholic steatohepatitis (NASH), cirrhosis or even hepatocellular carcinoma. NAFLD is major health burden, its incidence increasing worldwide. Although it primarily disturbed metabolism, involves several immune cell-mediated inflammatory processes, particularly when reaching the stage NASH, at which point inflammation becomes integral to progression disease. The cell landscape diverse steady state further evolves during NASH direct consequences for severity. In this Review, we discuss current concepts related role cells in onset NASH. A better understanding mechanisms by contribute pathogenesis should aid design innovative drugs target therapeutic options are limited. (NASH) serious chronic disorder prevalence Metabolic nature, also mobilizes system. Here, Huby Gautier knowledge regarding how subsets affect progression.

Language: Английский

Citations

379

Oxidative Stress in Liver Pathophysiology and Disease DOI Creative Commons
Abdolamir Allameh,

Reyhaneh Niayesh‐Mehr,

Azadeh Aliarab

et al.

Antioxidants, Journal Year: 2023, Volume and Issue: 12(9), P. 1653 - 1653

Published: Aug. 22, 2023

The liver is an organ that particularly exposed to reactive oxygen species (ROS), which not only arise during metabolic functions but also the biotransformation of xenobiotics. disruption redox balance causes oxidative stress, affects function, modulates inflammatory pathways and contributes disease. Thus, stress implicated in acute injury pathogenesis prevalent infectious or chronic diseases such as viral hepatitis B C, alcoholic fatty disease, non-alcoholic disease (NAFLD) steatohepatitis (NASH). Moreover, plays a crucial role progression fibrosis, cirrhosis hepatocellular carcinoma (HCC). Herein, we provide overview on effects pathophysiology mechanisms by promotes

Language: Английский

Citations

138

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease DOI Creative Commons

Yuanqiang Ma,

Gyurim Lee,

Suyoung Heo

et al.

Antioxidants, Journal Year: 2021, Volume and Issue: 11(1), P. 91 - 91

Published: Dec. 30, 2021

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic worldwide, and scientific studies consistently report that NAFLD development can be accelerated by oxidative stress. Oxidative stress induce progression of to NASH stimulating Kupffer cells, hepatic stellate hepatocytes. Therefore, are underway identify role antioxidants in treatment NAFLD. In this review, we have summarized origins reactive oxygen species (ROS) relationship between ROS NAFLD, discussed use as therapeutic agents for

Language: Английский

Citations

129

Fructose and the Liver DOI Open Access
Pablo Muriel, Pedro López‐Sánchez, Erika Ramos‐Tovar

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(13), P. 6969 - 6969

Published: June 28, 2021

Chronic diseases represent a major challenge in world health. Metabolic syndrome is constellation of disturbances affecting several organs, and it has been proposed to be liver-centered condition. Fructose overconsumption may result insulin resistance, oxidative stress, inflammation, elevated uric acid levels, increased blood pressure, triglyceride concentrations both the liver. Non-alcoholic fatty liver disease (NAFLD) term widely used describe excessive infiltration absence alcohol, autoimmune disorders, or viral hepatitis; attributed obesity, high sugar fat consumption, sedentarism. If untreated, NAFLD can progress nonalcoholic steatohepatitis (NASH), characterized by inflammation mild fibrosis addition and, eventually, advanced scar tissue deposition, cirrhosis, finally cancer, which constitutes culmination disease. Notably, fructose recognized as mediator NAFLD, significant correlation between intake degree found preclinical clinical studies. Moreover, risk factor for cancer development. Interestingly, induces number proinflammatory, fibrogenic, oncogenic signaling pathways that explain its deleterious effects body, especially

Language: Английский

Citations

109

Antioxidant Peptides from Monkfish Swim Bladders: Ameliorating NAFLD In Vitro by Suppressing Lipid Accumulation and Oxidative Stress via Regulating AMPK/Nrf2 Pathway DOI Creative Commons
Ming‐Feng Wu,

Qing-Hao Xi,

Sheng Yan

et al.

Marine Drugs, Journal Year: 2023, Volume and Issue: 21(6), P. 360 - 360

Published: June 16, 2023

In this study, we investigate the ameliorating functions of QDYD (MSP2), ARW (MSP8), DDGGK (MSP10), YPAGP (MSP13) and DPAGP (MSP18) from monkfish swim bladders on an FFA-induced NAFLD model HepG2 cells. The lipid-lowering mechanisms revealed that these five oligopeptides can up-regulate expression phospho-AMP-activated protein kinase (p-AMPK) proteins to inhibit sterol regulatory element binding protein-1c (SREBP-1c) increasing lipid synthesis up-regulating PPAP-α CPT-1 promoting β-oxidation fatty acids. Moreover, significantly reactive oxygen species' (ROS) production, promote activities intracellular antioxidases (superoxide dismutase, SOD; glutathione peroxidase, GSH-PX; catalase, CAT) bring down content malondialdehyde (MDA) derived peroxidation. Further investigations regulation oxidative stress was achieved through activating nuclear factor erythroid 2-related 2 (Nrf2) pathway raise levels heme oxygenase 1 (HO-1) downstream antioxidant proteases. Therefore, could serve as candidate ingredients develop functional products for treating NAFLD.

Language: Английский

Citations

77

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease DOI Open Access
Tobias Puengel, Hanyang Liu, Adrien Guillot

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(5), P. 2668 - 2668

Published: Feb. 28, 2022

Nonalcoholic fatty liver disease (NAFLD) and its progressive form nonalcoholic steatohepatitis (NASH) comprise a spectrum of chronic diseases in the global population that can lead to end-stage hepatocellular carcinoma (HCC). NAFLD is closely linked metabolic syndrome, comorbidities such as type 2 diabetes, obesity insulin resistance aggravate disease, while promotes cardiovascular risk affected patients. The pathomechanisms are multifaceted, combining hepatic factors including lipotoxicity, mechanisms cell death inflammation with extrahepatic disturbance dysbiosis. Nuclear receptors (NRs) family ligand-controlled transcription regulate glucose, fat cholesterol homeostasis modulate innate immune functions, macrophages. In parallel derangement NAFLD, altered NR signaling frequently observed might be involved pathogenesis. Therapeutically, clinical data indicate single drug targets thus far have been insufficient for reaching patient-relevant endpoints. Therefore, combinatorial treatment strategies multiple or drugs actions could possibly bring advantages, by providing more holistic therapeutic approach. this context, peroxisome proliferator-activated (PPARs) other NRs great interest they wide-ranging multi-organ activities associated NASH progression regression. review, we summarize recent advances understanding pathogenesis focusing on death, immunometabolism role NRs. We outline novel discuss remaining challenges.

Language: Английский

Citations

74

Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review DOI Creative Commons
Alessio Aghemo,

О. П. Алексеева,

Francesco Angelico

et al.

Annals of Medicine, Journal Year: 2022, Volume and Issue: 54(1), P. 1548 - 1560

Published: May 28, 2022

Chronic liver disease (CLD), manifested as hepatic injury, is a major cause of global morbidity and mortality. CLD progresses to fibrosis, cirrhosis, and—ultimately—hepatocellular carcinoma (HCC) if left untreated. The different phenotypes based on their respective clinical features causative agents include alcoholic (ALD), non-alcoholic fatty (NAFLD), metabolic-associated (MAFLD), drug-induced injury (DILI). preferred treatment modality for includes lifestyle modification diet, along with limited pharmacological symptomatic treatment. Moreover, oxidative stress (OS) an important pathological mechanism underlying all phenotypes; hence, the use antioxidants manage justified. Based available evidence, silymarin can be utilized hepatoprotective agent, given its potent antioxidant, antifibrotic, anti-inflammatory properties. role in suppressing OS has been well established, therefore recommended ALD NAFLD guidelines approved by Russian Medical Scientific Society Therapists Gastroenterology Russia. However, discuss positioning original protocols agent managing concomitantly other therapies, expert panel international medical professionals was convened 11 November 2020. reviewed approaches prevention OS, existing patient management CLD, evidence effectiveness reducing inflammation presented form narrative review.Key messagesAn ALD, NAFLD, MAFLD, DILI establish consensus recommendations that common pathophysiological these conditions.The also discussed therapies.The 140 mg three times day chronic diseases such DILI.

Language: Английский

Citations

69

Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway DOI

Yaxing Kang,

Yiran Song, Yuxin Luo

et al.

Free Radical Biology and Medicine, Journal Year: 2022, Volume and Issue: 192, P. 25 - 36

Published: Sept. 10, 2022

Language: Английский

Citations

69

Computational modeling of imines based anti-oxidant and anti-esterases compounds: Synthesis, single crystal and In-vitro assessment DOI
Muhammad Asam Raza, Umme Farwa, Muhammad Danish

et al.

Computational Biology and Chemistry, Journal Year: 2023, Volume and Issue: 104, P. 107880 - 107880

Published: May 8, 2023

Language: Английский

Citations

46

Oxidative Stress–Induced Liver Damage and Remodeling of the Liver Vasculature DOI Creative Commons
Priyanka Banerjee,

Niyanshi Gaddam,

Vanessa Chandler

et al.

American Journal Of Pathology, Journal Year: 2023, Volume and Issue: 193(10), P. 1400 - 1414

Published: June 23, 2023

As an organ critically important for targeting and clearing viruses, bacteria, other foreign material, the liver operates via immune-tolerant, anti-inflammatory mechanisms indispensable to immune response. Stress stress-induced factors disrupt homeostatic balance in liver, inflicting tissue damage, injury, remodeling. These include oxidative stress (OS) induced by viral infections, environmental toxins, drugs, alcohol, diet. A recurrent theme seen among stressors common multiple diseases is induction of mitochondrial dysfunction, increased reactive oxygen species expression, depletion ATP. Inflammatory signaling additionally exacerbates condition, generating a proinflammatory, immunosuppressive microenvironment activation apoptotic necrotic that integrity morphology. pathways initiate significantly contribute development steatosis, inflammation, fibrosis, cirrhosis, cancers. In addition, hypoxia OS directly enhance angiogenesis lymphangiogenesis chronic diseases. Late-stage consequences these conditions often narrow outcomes transplantation or result death. This review provides detailed perspective on various specific focus role different with special emphasis molecular mechanisms. It also highlights how resultant changes vasculature correlate pathogenesis. Stress-induced health issues are one major challenges modern society. Stress, which defined "conditions where demand exceeds natural regulatory capacity organism, particular situations unpredictability uncontrollability,"1Koolhaas J.M. Bartolomucci A. Buwalda B. de Boer S.F. Flugge G. Korte S.M. Meerlo P. Murison R. Olivier Palanza Richter-Levin Sgoifo Steimer T. Stiedl O. van Dijk Wohr M. Fuchs E. revisited: critical evaluation concept.Neurosci Biobehav Rev. 2011; 35: 1291-1301Crossref PubMed Scopus (982) Google Scholar can alter normal homeostasis human physiological psychological status.2Vere C.C. Streba C.T. L.M. Ionescu A.G. Sima F. Psychosocial disease status.World J Gastroenterol. 2009; 15: 2980-2986Crossref (65) Scholar,3Joung J.Y. Cho J.H. Kim Y.H. Choi S.H. Son C.G. literature injury.Brain Behav. 2019; 9e01235Crossref (43) Both experimental clinical studies show impacts hepatic physiology contributes Furthermore, it worsen patients cardiovascular diseases, cancer, HIV/AIDS.2Vere Scholar, 3Joung 4Cohen S. Janicki-Deverts D. Miller G.E. Psychological disease.JAMA. 2007; 298: 1685-1687Crossref (1952) Liver, largest solid body, center metabolism detoxification, site complex immunologic activity controlled diverse cells populations, as well nonhematopoietic cells.5Robinson M.W. Harmon C. O'Farrelly Liver immunology its inflammation homeostasis.Cell Mol Immunol. 2016; 13: 267-276Crossref (598) receives digested products, microbial agents, antigens from body through portal vein, elicit cell cause persistent regulated inflammation.6Racanelli V. Rehermann The immunological organ.Hepatology. 2006; 43: S54-S62Crossref (967) Prolonged exposure high-fat diet, hormones causes leading diseases.7Ozkan Stolley Cressman E.N.K. McMillin DeMorrow Yankeelov T.E. Rylander M.N. influence vasculature: liver-on-a-chip review.Micromachines (Basel). 2020; 11: 487Crossref Episodes such physiological, psychological, have negative impact long-term pre-existing conditions, hepatitis B virus (HBV),8Kunkel E.J. J.S. Hann H.W. Oyesanmi Menefee L.A. Field H.L. Lartey P.L. Myers R.E. Depression Korean immigrants related diseases.Psychosomatics. 2000; 41: 472-480Crossref (57) C (HCV),9Nagano J. Nagase Sudo N. Kubo stress, personality, severity C.Psychosomatics. 2004; 45: 100-106Crossref (38) alcoholic hepatitis,10Fukudo Suzuki Tanaka Y. Iwahashi Nomura Impact injury; histopathological study.J Psychosom Res. 1989; 33: 515-521Crossref nonalcoholic steatohepatitis,11Elwing J.E. Lustman P.J. Wang Clouse Depression, anxiety, steatohepatitis.Psychosom Med. 68: 563-569Crossref (100) (OS), endoplasmic reticulum (ER) hepatocellular carcinoma (HCC).12Luna-Marco Ubink Kopsida Heindryckx Endoplasmic carcinoma.Am Pathol. 2023; 193: 1377-1388Abstract Full Text PDF Scholar,13Brahma M.K. Gilglioni E.H. Zhou L. Trepo Chen Gurzov E.N. Oxidative obesity-associated carcinoma: sources, therapeutic challenges.Oncogene. 2021; 40: 5155-5167Crossref (16) stress-mediated damages, both hepatocytes nonparenchymal cells, present vasculature, impacted.7Ozkan current principal contributing damage progression disease. highly vascularized dense network blood vessels, bile ducts, lymphatic vessels. plays transforming toxic substances into form be eliminated. Compared organs has high receive cardiac output, up 25% output at rest.14Abdel-Misih S.R. Bloomston anatomy.Surg Clin North Am. 2010; 90: 643-653Abstract (179) first nutrient-rich intestines participates response.15Gibert-Ramos Sanfeliu-Redondo Aristu-Zabalza Martinez-Alcocer Gracia-Sancho Guixe-Muntet Fernandez-Iglesias sinusoid disease: optimal milieu cancer.Cancers 5719Crossref (4) unique because superimposition two inlet networks (ie, artery vein), running parallel; outlet composed central veins, veins.16Lorente Hautefeuille Sanchez-Cedillo functionalized vascular structure.Sci Rep. 1016194Crossref (28) vein play maintaining supply liver. divided hexagonal lobules, consist triads, resident cells. triad artery, ducts7Ozkan Scholar,17Fleischer J.R. Jodszuweit C.A. Ghadimi De Oliveira Conradi L.C. Vascular heterogeneity microenvironment.Front Physiol. 11591901Crossref (Figure 1). collects digestive tract, pancreas, spleen, approximately 75% liver's supply, whereas remaining supplied artery. venous mixes oxygenated flows sinusoid, microvascular bed sinusoids send vein.7Ozkan sinusoidal endothelial (LSECs) morphologically functionally they clustered fenestrations sieve plates,16Lorente discontinuous arrangement, lack typical basement membrane, attenuated extracellular matrix fibronectin component.18Xu Broome U. Uzunel Nava Ge X. Kumagai-Braesch Hultenby K. Christensson Ericzon B.G. Holgersson Sumitran-Holgersson Capillarization cell-reactive autoantibodies cirrhosis hepatitis.Am 2003; 163: 1275-1289Abstract adult length 250 μm, their diameter varies between 7 15 μm.19Vollmar Menger M.D. microcirculation: mechanistic contributions targets injury repair.Physiol 89: 1269-1339Crossref (368) Under arrangement LSECs facilitates exchange large molecules pathogens blood.18Xu Bile ducts carry gallbladder direction opposite sinusoids.20Du Khandekar Llewellyn Polacheck W. C.S. Wells R.G. duct-on-a-chip organ-level functions.Hepatology. 71: 1350-1363Crossref (41) Along system maintenance fluid homeostasis, response.21Burchill M.A. Goldberg A.R. Tamburini B.A.J. Emerging roles lymphatics disease.Front 10: 1579Crossref (11) Scholar,22Roy Banerjee Ekser Bayless Zawieja Alpini Glaser S.S. Chakraborty Targeting lymph node metastasis cancer.Am 191: 2052-2063Abstract (0) Recent murine models organized segmentally, intrahepatic vessels populated around triad.23Frenkel N.C. Poghosyan Verheem Padera T.P. Rinkes I. Kranenburg Hagendoorn drainage patterns follow segmental anatomy model.Sci 1021808Crossref Lymphatic capillaries, thin-walled single layered (LECs), collect lymph, rich cellular proteins, lipoproteins, lymphocytes, drain collecting Collecting unlike covered muscle pump nodes.21Burchill Scholar,24Tanaka Iwakiri system: structure, function, markers, lymphangiogenesis.Cell Gastroenterol Hepatol. 2: 733-749Abstract About 70% 80% parenchymal hepatocytes. Hepatocytes crucial metabolism, innate regulation, protein synthesis, secretion circulation.25Schulze R.J. Schott M.B. Casey Tuma McNiven biology hepatocyte: membrane trafficking machine.J Cell Biol. 218: 2096-2112Crossref (80) Scholar,26Zhou Z. Xu M.J. Gao Hepatocytes: key type immunity.Cell 301-315Crossref (247) main proteins secreted α-fetoprotein, serum albumin, transferrin, plasminogen, fibrinogen, α-1-antitrypsin, C-reactive protein, clotting (except factor VIII).25Schulze initiation acid (BA) then transported canaliculi. BAs take part emulsification, digestion dietary fats, removal metabolic wastes.25Schulze series ductules eventually transferred stored there until being hormonally stimulated released intestines. However, retained impaired toxicity.27Fang Han S.I. Mitchell Gupta Studer Grant Hylemon P.B. Dent acids induce ROS, promote receptor tyrosine kinases rat hepatocytes.Hepatology. 961-971Crossref (106) pathologic enhanced level BAs, deoxycholic acids, taurodeoxycholic (ROS) production, which, turn, activates downstream signal-regulated kinase 1/2 AKT pathways.27Fang ROS-mediated damage. High ROS stimulates hypertonicity, release cytochrome c hepatocyte apoptosis.28Wei Ma Zhao Mechanism hydrophobic acid-induced drug discovery.Front Pharmacol. 1084Crossref (26) three-dimensional duct, biliary tree, lined heterogeneous, dynamic population epithelial cholangiocytes, represent only 3% 5% total population.29Banales Huebert R.C. Karlsen Strazzabosco LaRusso N.F. Gores G.J. Cholangiocyte pathobiology.Nat Rev 16: 269-281Crossref (237) cholangiocytes responsible 30% flow humans, produced hepatocytes.29Banales Cholangiocytes activated several stimuli, xenobiotic cholestasis, ischemia, OS. Activated altered proliferation secrete variety profibrotic proinflammatory factors.29Banales Scholar,30Ostrycharz Wasik Kempinska-Podhorodecka Banales Milkiewicz Melatonin protects proapoptotic stimuli miR-132 miR-34.Int Sci. 21: 9667Crossref (13) Hepatic stellate (HSCs), 10% liver-specific fibroblasts reside space Disse, healthy HSCs primary storage sites vitamin A.15Gibert-Ramos case get activated, differentiate myofibroblasts, produce components, fibrosis Interestingly, plethora cytokines chemokines, monocyte chemoattractant 1, IL-6, growth factor-β, enable leukocyte recruitment Recruited leukocytes response further HSCs.31Winau Quack Darmoise Kaufmann Starring immunology.Curr Opin 2008; 20: 68-74Crossref (70) OS, activate quiescent long run, HCC.32Ramos-Tovar Muriel Molecular link liver.Antioxidants 9: 1279Crossref (99) Kupffer (KCs) macrophages adherent wall KCs serves line defense against bacterial infection host response.33Fox E.S. Thomas Broitman S.A. Comparative endotoxin uptake isolated peritoneal cells.Infect Immun. 1987; 55: 2962-2966Crossref 34Bilzer Roggel Gerbes A.L. Role disease.Liver Int. 26: 1175-1186Crossref (651) 35Bleriot Dupuis Jouvion Eberl Disson Lecuit Liver-resident macrophage necroptosis orchestrates 1 microbicidal type-2-mediated repair during infection.Immunity. 2015; 42: 145-158Abstract (309) differentiated M1-like (classic) M2-like (alternative) macrophages. sources cytokines, damage.36Liu Tao Q. Sun Wu J.Z. Yang Jian Peng Hu Liu associated apoptosis, fibrotic effects rats.Lab Invest. 1805-1816Abstract (109) Scholar,37Zhang Zhu X.D. H.C. Xiong Y.Q. Zhuang P.Y. H.X. Kong L.Q. W.Z. Tang Z.Y. Depletion tumor-associated enhances effect sorafenib metastatic cancer antimetastatic antiangiogenic effects.Clin Cancer 3420-3430Crossref (313) oxidized low-density lipoprotein, lipopolysaccharide, infiltrating NADPH oxidase 2 (Nox2), stimulate [eg, tumor necrosis (TNF)-α, IL-1β].38Kim S.Y. Jeong S.J. Seo M.H. W.M. Yoo Lee Shim Y.R. Yi H.S. Y.S. Eun B.S. Chun Kang S.C. Kunos H.M. W.I. Pro-inflammatory generate endocytosis monomeric TLR4-MD2 complex.Nat Commun. 2017; 8: 2247Crossref (147) specialized interface lumen contrast display clusters plates.39Wisse Zanger R.B. Charels Van Der Smissen McCuskey R.S. sieve: considerations concerning structure function fenestrae, Disse.Hepatology. 1985; 5: 683-692Crossref (581) Because permeable membrane.40Braet Wisse Structural functional aspects fenestrae: review.Comp 2002; 1: 1Crossref (572) selectively control diffusion substrate Disse.41Poisson Lemoinne Boulanger Durand Moreau Valla Rautou P.E. cells: diseases.J 66: 212-227Abstract (549) Scholar,42Geraud Evdokimov Straub B.K. Peitsch W.K. Demory Dorflinger Schledzewski Schmieder Schemmer Augustin H.G. Schirmacher Goerdt Unique type-specific junctional complexes endothelium sinusoids.PLoS One. 2012; 7e34206Crossref (48) phenotypes maintained factor-A (VEGF-A) stimulation nitric oxide–dependent oxide–independent signaling.43Xie Atkinson R.D. Kanel G.C. Gaarde W.A. Deleve L.D. differentiation regression rats.Gastroenterology. 142: 918-927.e6Abstract (259) keep quiescent. source fibrillar collagens components scar.44Wells Cellular fibrosis.Clin Dis. 12 (viii): 759-768Abstract (146) Scholar,45Kisseleva Brenner regression.Nat 18: 151-166Crossref (594) diseased damaged factor-β hepatocytes, damage.7Ozkan Scholar,34Bilzer lymph-producing system.46Tanaka Lymphatics liver.Curr 2018; 53: 137-142Crossref plasma component filtered fenestrae Disse. mall, enters interstitial triad, finally capillaries.24Tanaka primarily located nearby draining nodes outside liver.47Ohtani Ohtani Lymph circulation liver.Anat Rec (Hoboken). 291: 643-652Crossref (138) Inside LECs, identified markers vessel hyaluronan (Lyve-1), prospero homeobox (Prox1), podoplanin, absence α-smooth actin–positive (smooth cells/pericytes). express Lyve-1, Prox1.48Truman Bentley K.L. Smith E.C. Massaro Gonzalez D.G. Haberman A.M. Hill Jones Min Krause D.S. Ruddle N.H. ProxTom reporter mice reveal Prox1 expression adrenal medulla, megakaryocytes, platelets.Am 180: 1715-1725Abstract Thus, co-existence above three identifies LECs. livers, LECs required maintain fat cholesterol scavenger class I.49Lim H.Y. Thiam C.H. Yeo K.P. Bisoendial Hii McGrath K.C. Tan K.W. Heather Alexander Angeli essential peripheral tissues SR-BI-mediated transport HDL.Cell Metab. 2013; 17: 671-684Abstract (217) Scholar,50Martel Randolph Atherosclerosis transit HDL vasculature.Curr Atheroscler 354Crossref (22) Several report that, under production increases expansion lymphangiogenesis.24Tanaka Scholar,51Banerjee Kumaravel Roy Gaddam Odeh K.J. Conjugated modulation species-p90RSK-vascular 3 pathway.Cells. 12: 526Crossref 52Singla Aithabathula R.V. Kiran Kapil Kumar Singh U.P. Reactive regulating function.Cells. 2022; 1750Crossref Schola

Language: Английский

Citations

42